FDA clears CardioVascular Dynamic's neonate vascular access devices:
This article was originally published in Clinica
Executive Summary
CardioVascular Dynamics has received FDA clearance to market a tiny device for accessing veins and arteries of newborn children. The company said its PD Access device uses a miniature Doppler ultrasound circuit, which measures less than 0.003mm, placed at the tip of a catheter or vascular access needle. The devices are small enough to be used on patients weighing from 0.5kg to 5kg.
You may also be interested in...
Sanofi Skates To Where The Puck Is With Immunology
The French drugmaker has not abandoned oncology but has made it very clear that immunology and inflammation is the priority for its R&D euros.
Pipeline Watch: Five Approvals And 23 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Lack Of Industry Involvement In EU HTA Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.